Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
-
Published:2022-05-05
Issue:249
Volume:60
Page:488-490
-
ISSN:1815-672X
-
Container-title:Journal of Nepal Medical Association
-
language:
-
Short-container-title:J Nepal Med Assoc
Author:
Das Sunil KumarORCID,
Shahi Arun,
Panthi Ram Chandra
Abstract
Choriocarcinoma is a malignant trophoblastic tumour usually of placental origin. It is characterized by early metastasis to the brain and lungs. With early detection, it has a better prognosis with treatment. We report a case of 18 years female at 26 weeks of gestation in her third pregnancy who had a history of treatment for metastatic gestational trophoblastic neoplasm with chemotherapy and radiotherapy two years back. Therefore, she was managed as a case of recurrent choriocarcinoma with brain metastasis with chemotherapy (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) and was responsive. Her symptoms resolved and β-human chorionic gonadotropin dropped to normal value (<2.39 mIU/ml) which has shown that timely diagnosis and management can be vital for the successful treatment of brain metastasis.
Publisher
Journal of Nepal Medical Association (JNMA)